Diabetes

Top news of the day from across the health care landscape.

A lack of IRS-1 expression observed to increase cell proliferation in blood vessels of the heart.

Insulin could become a new therapeutic option for HIV-associated neurocognitive disorders.

Pramlintide help to create a blood test for Alzheimer’s disease.

A variant of SEMA4D may be why there is a high prevalence of obesity among individuals of African ancestry.

Lilly Diabetes expands sponsorship of driver with diabetes.

A periodic water-only diet may improve glucose control in diabetes.

A 2-drug combination reduced retinal cell death more effectively than a single drug therapy.

Diabetes management cost the United States an estimated $245 billion in 2012, including $176 billion for direct treatment and complications.

Advocacy group warns that American Health Care Act may harm patients with diabetes.

Sustained and controllable insulin delivery may improve diabetes care.

Long-term metformin therapy associated with lower serum vitamin B12 concentration.

Patients with type 2 diabetes administered long-term metformin more likely not to have vitamin B12 levels monitored.

African Americans with sickle cell trait may have inaccurate HbA1c test results.

The TrpC5 ion channel is necessary for appetite suppression regulated by leptin or lorcaserin.

New research conducted by the London Metropolitan University suggests that patients may be able to follow a reduced carb diet as an effective and safe strategy for managing their diabetes.

New treatment approach harnesses the abilty of liver cells to burn accumulated fats.

Certain beta cells are able to evade an immune system attack in type 1 diabetes.

A collaborative clinic could save more than $5000 per patient over 3 years.

Genetics that determine physical traits may play a large role in prevalence of conditions such as multiple sclerosis, autism, and diabetes.

This article will highlight several key therapeutics areas with lixisenatide that every pharmacist should know.

The first of 4 new clinical trial of artificial pancreas systems has begun, which could benefit patients with type 2 diabetes.

Chronic exposure to air pollution may have a wide-reaching impact on children’s health.

Young individuals with type 2 diabetes are more likely to develop condition-related complications than their type 1 counterparts.

Liraglutide reduced the risk of type 2 diabetes by 80%.